Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors

Enhancer of zeste homolog 2 inhibitors (EZH2i) have garnered increased attention owing to their anticancer activity by targeting EZH2, a well-known cancer-promoting factor. However, some lymphomas are resistant to EZH2i, and EZH2i treatment alone is ineffective in case of EZH2-overexpressing solid t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chen, Wang, Yan, Gong, Yueqing, Zhang, Tengrui, Huang, Jiaqi, Tan, Zhen, Xue, Lixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992945/
https://www.ncbi.nlm.nih.gov/pubmed/33761979
http://dx.doi.org/10.1186/s13148-021-01045-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992945/
https://www.ncbi.nlm.nih.gov/pubmed/33761979
http://dx.doi.org/10.1186/s13148-021-01045-1

Ejemplares similares